(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.
Diabetic Mellitus
Protein Kinase C beta Inhibitor - Albuminuria Study in Patients with Type 2 Diabetes Mellitus. The purpose of this trial is to determine whether the investigational drug can reduce urinary albumin/creatinine excretion in patients with Type II diabetes and persistent albuminuria, whether the investigational drug reduces urinary TGF-beta and the safety of the investigational drug and any side effects that may be associated with it. Research sites throughout the USA.
More Information
Please see http://www.centerwatch.com/patient/studies/cat55.html.
-----
Cancer Prevention
Selenium and Vitamin E Cancer Prevention Trial (SELECT). A 12-year national study designed to test the effectiveness of Selenium and Vitamin E in the prevention of prostate cancer. Research site in New York.
More Information
Please see http://www.centerwatch.com/patient/studies/cat580.html.
-----
Chronic Pain
A randomized, double-blind, placebo-controlled research study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Research sites throughout the USA.
More Information
Please see http://www.centerwatch.com/patient/studies/cat45.html.
-----
Copyright 2002 Centerwatch. All rights reserved.
